La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Humana Gestione

Gestione criteri di controllo 2/4

Humana's Il CEO è Jim Rechtin, nominato in Jan2024, ha un mandato di meno di un anno. possiede direttamente 0% delle azioni della società, per un valore di MX$ 78.62K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2 anni e 3.9 anni.

Informazioni chiave

Jim Rechtin

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	0.00001%
Durata media del management	2.2yrs
Durata media del Consiglio di amministrazione	4.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Jim Rechtin (53 yo)

less than a year

Mandato

Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Susan Diamond	Chief Financial Officer	3.3yrs	US$4.73m	0.0072% MX$ 46.0m
Joseph Ventura	Chief Legal Officer	5.7yrs	US$3.10m	0.0060% MX$ 38.6m
Bruce Broussard	Strategic Advisor	less than a year	US$16.33m	0.073% MX$ 469.2m
George Renaudin	President of Medicare & Medicaid	1.7yrs	US$3.11m	0.0032% MX$ 20.2m
Sanjay Shetty	President of CenterWell	1.6yrs	US$4.58m	0.00014% MX$ 895.3k
James Rechtin	President	less than a year	Nessun dato	0.000010% MX$ 63.9k
John-Paul Felter	Senior VP	2.2yrs	Nessun dato	0.00031% MX$ 2.0m
Eric Tagliere	Senior VP & CTO	less than a year	Nessun dato	Nessun dato
Samir Deshpande	Chief Information Officer	3.8yrs	Nessun dato	0.010% MX$ 65.9m
Timothy Huval	Chief Administrative Officer	5.3yrs	US$3.73m	0.0061% MX$ 39.3m
Lisa Stoner	Vice President of Investor Relations	no data	Nessun dato	Nessun dato
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.8yrs	Nessun dato	0.0090% MX$ 57.8m

2.2yrs

Durata media

51.5yo

Età media

Gestione esperta: Il team dirigenziale di HUM * è considerato esperto (durata media dell'incarico 2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
James Rechtin	President	less than a year	Nessun dato	0.000010% MX$ 63.9k
Kurt Hilzinger	Independent Chairman of the Board	21.3yrs	US$601.30k	0.016% MX$ 103.3m
Karen Katz	Independent Director	5.1yrs	US$346.55k	0.00049% MX$ 3.1m
Frank D'Amelio	Independent Director	21.1yrs	US$363.55k	0.017% MX$ 109.6m
Jorge Mesquita	Independent Director	3.7yrs	US$351.59k	0.0018% MX$ 11.4m
Brad Smith	Independent Director	2.1yrs	US$311.07k	0.00032% MX$ 2.0m
Wayne Frederick	Independent Director	4.7yrs	US$364.87k	0.00037% MX$ 2.4m
David Feinberg	Independent Director	2.6yrs	US$321.52k	0.00037% MX$ 2.4m
Marcy Klevorn	Independent Director	3.7yrs	US$351.94k	0.00036% MX$ 2.3m
John Garratt	Independent Director	4.7yrs	US$326.03k	0.0010% MX$ 6.7m
RaQuel Bono	Independent Director	4.1yrs	US$345.03k	0.00033% MX$ 2.1m

4.1yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HUM * sono considerati esperti (durata media dell'incarico 3.9 anni).

Humana Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Announces Management Changes

High number of new directors

High number of new directors

Chief Financial Officer recently sold Mex$7.4m worth of stock

Recent updates

Investor sentiment deteriorates as stock falls 21%

Humana Inc. to Report Q3, 2024 Results on Oct 30, 2024

Upcoming dividend of US$0.89 per share

Second quarter dividend of US$0.89 announced

Second quarter dividend of US$0.89 announced

Humana Settles for $90 Million Groundbreaking False Claims Act Case Alleging Medicare Part D Prescription Drug Program Fraud

Humana Inc. Declares Cash Dividend, Payable on October 25, 2024

Second quarter 2024 earnings released: EPS: US$5.64 (vs US$7.70 in 2Q 2023)

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: US$6.13 (vs US$9.91 in 1Q 2023)

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Dividend of US$0.89 announced

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana Inc. Provides Earnings Guidance for 2024

Humana Announces Limited Layoffs

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings released: EPS: US$6.74 (vs US$9.44 in 3Q 2022)

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

High number of new directors

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Centerwell Senior Primary Care Introduces In-Home Primary Care

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: US$7.70 (vs US$5.50 in 2Q 2022)

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Upcoming dividend of US$0.89 per share at 0.8% yield

High number of new directors

Chief Financial Officer recently sold Mex$7.4m worth of stock

First quarter 2023 earnings released

High number of new directors

Humana Inc. Declares Cash Dividend, Payable on April 28, 2023

Full year 2022 earnings released: EPS: US$22.20 (vs US$22.79 in FY 2021)

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Humana Inc. to Report Q4, 2022 Results on Feb 01, 2023

Independent Director recently sold Mex$148m worth of stock

Upcoming dividend of US$0.79 per share

President recently sold Mex$74m worth of stock

Humana Inc. Provides Earning Guidance for Fiscal Year 2022

Humana Inc. Declares Cash Dividend to Stockholders, Payable on January 27, 2023

Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs

Humana Inc. to Report Q3, 2022 Results on Nov 02, 2022

Humana Reportedly Among Firms Looking to Buy Cano Health

Chief Legal Officer recently sold Mex$12m worth of stock

Upcoming dividend of US$0.79 per share

Humana Elects Brad D. Smith to Board of Directors

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, October 28, 2022

Humana Inc. (NYSE:HUM) agreed to acquire Substantially All of the Assets of Inclusa, Inc.

Second quarter 2022 earnings released: EPS: US$5.50 (vs US$4.57 in 2Q 2021)

Humana Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Humana Inc. to Report Q2, 2022 Results on Jul 27, 2022

Humana Inc. Announces Management Changes

Upcoming dividend of US$0.79 per share

Chief Information Officer recently sold Mex$35m worth of stock

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, Payable on July 29, 2022

Humana Inc. to Report Q1, 2022 Results on Apr 27, 2022

Upcoming dividend of US$0.79 per share

Humana Inc. Announces Executive Changes, Effective March 31, 2022

Humana Board Declares Payment of Quarterly Dividend to Stockholders, Payable on April 29, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations